Guardant Health Inc (NASDAQ: GH) is 21.41% higher on its value in year-to-date trading and has touched a low of $20.14 and a high of $52.92 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The GH stock was last observed hovering at around $39.97 in the last trading session, with the day’s loss setting it -2.88%.
Currently trading at $37.09, the stock is -14.49% and -14.89% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 2.16 million and changing -7.21% at the moment leaves the stock 5.85% off its SMA200. GH registered 41.35% gain for a year compared to 6-month gain of 27.41%. The firm has a 50-day simple moving average (SMA 50) of $43.5784 and a 200-day simple moving average (SMA200) of $35.03905.
The stock witnessed a -15.32% loss in the last 1 month and extending the period to 3 months gives it a -21.75%, and is -8.91% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 3.51% over the week and 5.74% over the month.
Guardant Health Inc (GH) has around 2021 employees, a market worth around $4.60B and $774.00M in sales. Profit margin for the company is -53.82%. Distance from 52-week low is 84.16% and -29.91% from its 52-week high. The company has generated returns on investments over the last 12 months (-40.60%).
The EPS is expected to grow by 22.03% this year
461.0 institutions hold shares in Guardant Health Inc (GH), with institutional investors hold 102.76% of the company’s shares. The shares outstanding are 123.65M, and float is at 117.61M with Short Float at 6.56%. Institutions hold 97.85% of the Float.
The top institutional shareholder in the company is VANGUARD GROUP INC with over 11.64 million shares valued at $336.07 million. The investor’s holdings represent 9.5035 of the GH Shares outstanding. As of 2024-06-30, the second largest holder is BLACKROCK INC. with 11.24 million shares valued at $324.55 million to account for 9.1777 of the shares outstanding. The other top investors are BAILLIE GIFFORD & CO which holds 6.09 million shares representing 4.9763 and valued at over $175.97 million, while DEEP TRACK CAPITAL, LP holds 3.6751 of the shares totaling 4.5 million with a market value of $129.96 million.
Guardant Health Inc (GH) Insider Activity
The most recent transaction is an insider sale by Tariq Musa, the company’s Director. SEC filings show that Tariq Musa sold 116 shares of the company’s common stock on May 19 ’25 at a price of $40.04 per share for a total of $4645.0. Following the sale, the insider now owns 3479.0 shares.
Still, SEC filings show that on May 01 ’25, Talasaz AmirAli (Co-Chief Executive Officer) disposed off 106,784 shares at an average price of $49.01 for $5.23 million. The insider now directly holds 2,202,672 shares of Guardant Health Inc (GH).
